KEROS THERAPEUTICS INC. - COMMON STOCK
10,98
20-февраля-25 15:29:46
15 мин. задержка
Акции
+0,37
+3,49%
Сегодняшний диапазон
10,59 - 11,12
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Keros Therapeutics to Present at the Guggenheim SMID Cap Biotech Conference
30 янв 2025 08:00:00 Источник Nasdaq GlobeNewswire
-
21 янв 2025 08:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Announces Additional Update on the Phase 2 TROPOS Trial
15 янв 2025 06:30:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Announces Update on the Phase 2 TROPOS Trial
12 дек 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
09 дек 2024 19:30:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Announces Global License Agreement with Takeda to Advance Elritercept
03 дек 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences
26 ноя 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at the Guggenheim Healthcare Innovation Conference
06 ноя 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
05 ноя 2024 09:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Appoints Yung H. Chyung, M.D., as Chief Medical Officer
16 окт 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
12 сен 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Announces Update on Enrollment in the Phase 2 TROPOS Trial
03 сен 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences
28 авг 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Reports Second Quarter 2024 Financial Results
07 авг 2024 16:01:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Announces Leadership Updates
17 июн 2024 16:01:02 Источник Nasdaq GlobeNewswire
-
17 июн 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics to Host a Corporate Update Conference Call and Webcast
04 июн 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at Goldman Sachs 45th Annual Global Healthcare Conference
03 июн 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors
28 май 2024 16:01:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at the 29th Annual Congress of the European Hematology Association
14 май 2024 10:00:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >